Clinical trial
Prone to Supine Breast MRI Trial II, P2S2 MRI Trial
NCT05131607 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prone to Supine Breast MRI Trial II, P2S2 MRI Trial
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 17, 2022
- Completion date
- March 31, 2024
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer female